Author: sciadseo

SolentimArticles by: sciadseo
Corporate sciadseo

Solentim agrees exclusive distribution deal with Matrixome to supply clinical manufacturing grade laminin to cell therapy market

Bournemouth, UK, 10th June 2021 / Solentim, the trusted global leader for solutions to create, isolate, and characterize the highest value cells for the development of new biological medicines, has today announced an exclusive distribution agreement with Matrixome Inc. (Japan) for use in conjunction with Solentim’s instrumentation. Under the new agreement, Solentim will add a clinical manufacturing-grade …

Read more Solentim agrees exclusive distribution deal with Matrixome to supply clinical manufacturing grade laminin to cell therapy market

Conferences sciadseo

Connect with Solentim at ISSCR

Solentim, the trusted global leader for solutions to create, isolate, and characterize the highest value cells for the development of new biological medicines, is delighted to announce that it will be presenting and exhibiting at the ISSCR 2021 Annual Meeting, taking place virtually, 21-26 June 2021. Dr Ian Taylor, Chief Business Officer, Solentim will present …

Read more Connect with Solentim at ISSCR

Conferences sciadseo

Solentim will present at ASGCT 24th Annual Meeting

Solentim, the trusted global leader for solutions to create, isolate, and characterize the highest value cells for the development of new biological medicines, is pleased to announce that it will be presenting at American Society of Gene & Cell Therapy 24th Annual Meeting, 11-14th May. Dr Ian Taylor, Chief Business Officer, Solentim, will present on Thursday 13th May, …

Read more Solentim will present at ASGCT 24th Annual Meeting

Product sciadseo

Cell line development partners deliver technology breakthrough

A project consortium involving Solentim, ValitaCell and Microcoat has successfully developed an integrated technology platform for biologics and cell therapy. In 2019, the consortium partners raised €3.5M to advance the project which has culminated in the launch of the ICON™ instrument by Solentim. ICON™ is designed to enhance commercial laboratory workflows involved in development of new therapeutic antibodies. …

Read more Cell line development partners deliver technology breakthrough

Insights sciadseo

Feature Article: The Next Generation of Cell Factories for Viral Vector Production

The true potential of gene therapy – with the incredible promise to treat a vast variety of diseases – will only be realised through enhanced manufacturing practices. In a recent article published in Genetic Engineering and Biotechnology News, the technologies, approaches and tools needed to standardize viral vector production and ensure the pipeline meets GMP …

Read more Feature Article: The Next Generation of Cell Factories for Viral Vector Production